Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Benefit From a Proximity-incentive Strategy Based on Vaginal Self-sampling for Women Who do Not Participate to Cervical Cancer Screening in Aude and Hérault [French Departments]: an Interventional Research to Reduce Social and Territorial Inequalities.

NCT04716127 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT04716127
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04716127 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Benefit From a Proximity-incentive Strategy Based on Vaginal Self-sampling for Women Who do Not Participate to Cervical Cancer Screening in Aude and Hérault [French Departments]: an Interventional Research to Reduce Social and Territorial Inequalities.
Lead sponsor
University Hospital, Montpellier
Phase
Not applicable
Overall status
Completed
Start date
September 16, 2021
Completion date
July 25, 2024
Enrollment
656 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, human papilloma virus, uterine cervical disease